Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs

Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and significant inter-individual variability in blood concentrations. This variability can be because of factors like drug-nutrient interactions, drug-disease interactions, renal-insufficiency, inflammation and infection, gender, age, polymorphism and liver mass. Drug monitoring is widely practiced ...

متن کامل

Use of saliva in therapeutic drug monitoring.

We measured the concentrations of phenobarbital, phenytoin, primidone, ethosuximide, antipyrine, and caffeine in paired samples of saliva and plasma by gas chromatograph-mass spectrometer-computer (GC/MS/COM) and enzyme immunoassay. Mixed saliva was collected for the antipyrine and caffeine studies, parotid saliva for the phenobarbital, primidone, ethosuximide and phenytoin studies. The saliva/...

متن کامل

Biomedical Application of a Novel Nanostructured-based Electrochemical Platform for Therapeutic Monitoring of an Antiepileptic Drug; Gabapentin

Herein, gold nanoparticle had been successfully synthesized through a simple, inexpensive and clean electrochemical technique. Gold nanoparticles were directly deposited on the electrode surface using an electrochemical strategy. Then, the electrochemical deposition parameters (such as applied potential and deposition time) were optimized. 1.1 V and 250 s were applied as the optimal electrodepo...

متن کامل

Pharmacogenetic information for patients on drug labels

Advances in pharmacogenetic research have improved our understanding of adverse drug responses and have led to the development of pharmacogenetic tests and targeted drugs. However, the extent of the communication process and provision of information to patients about pharmacogenetics is unclear. Pharmacogenetic information may be included in sections of a drug's package insert intended for pati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: YAKUGAKU ZASSHI

سال: 2018

ISSN: 0031-6903,1347-5231

DOI: 10.1248/yakushi.18-00114